Atıf Formatları
Demographic and clinical features of patients with metastatic HER2 positive breast cancer: a retrospective multicenter registry study of the Turkish Oncology Group
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Y. Eralp Et Al. , "Demographic and clinical features of patients with metastatic HER2 positive breast cancer: a retrospective multicenter registry study of the Turkish Oncology Group," San Antonio Breast Cancer Symposium , San-Antonio, Northern Mariana Islands, 2022

Eralp, Y. Et Al. 2022. Demographic and clinical features of patients with metastatic HER2 positive breast cancer: a retrospective multicenter registry study of the Turkish Oncology Group. San Antonio Breast Cancer Symposium , (San-Antonio, Northern Mariana Islands).

Eralp, Y., Dogan, I., AKSOY, S., Cakar, B., Basaran, G., Ercelep, O., ... Molinas Mandel, N.(2022). Demographic and clinical features of patients with metastatic HER2 positive breast cancer: a retrospective multicenter registry study of the Turkish Oncology Group . San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands

Eralp, YEŞİM Et Al. "Demographic and clinical features of patients with metastatic HER2 positive breast cancer: a retrospective multicenter registry study of the Turkish Oncology Group," San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 2022

Eralp, YEŞİM Et Al. "Demographic and clinical features of patients with metastatic HER2 positive breast cancer: a retrospective multicenter registry study of the Turkish Oncology Group." San Antonio Breast Cancer Symposium , San-Antonio, Northern Mariana Islands, 2022

Eralp, Y. Et Al. (2022) . "Demographic and clinical features of patients with metastatic HER2 positive breast cancer: a retrospective multicenter registry study of the Turkish Oncology Group." San Antonio Breast Cancer Symposium , San-Antonio, Northern Mariana Islands.

@conferencepaper{conferencepaper, author={YEŞİM ERALP Et Al. }, title={Demographic and clinical features of patients with metastatic HER2 positive breast cancer: a retrospective multicenter registry study of the Turkish Oncology Group}, congress name={San Antonio Breast Cancer Symposium}, city={San-Antonio}, country={Northern Mariana Islands}, year={2022}}